Summary
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.
History
LifeTech Scientific Co Ltd was founded in 2004 by Dmitry Moiseev and Vladimir Yuriev. Since then, our company has become a leader in the development and distribution of medical devices, biotechnologies, and diagnostic products and services. We are committed to bettering our customers’ healthcare experience and providing them with access to the best possible treatments.
Mission
Our mission is to create innovative solutions that improve the lives of people everywhere. Through our commitment to innovation and quality, we strive to become the most trusted and respected provider of healthcare services.
Vision
Our vision is to revolutionize healthcare through the use of advanced medical and biotechnological solutions that enable us to provide affordable and intuitive care. Our goal is to be the leader in developing innovative and comprehensive solutions that will improve the quality of life of patients, improve their treatment options, and lower healthcare costs.
Key Team
Mr. Yuehui Xie (Chairman & CEO)
Mr. Jianxiong Liu (CFO, Exec. VP, Company Sec. & Exec. Director)
Jerry Zhu (Investor Relations Mang.)
Recognition and Awards
LifeTech Scientific Co Ltd has won many awards for its products and services, including the 2019 'Best Medical Technology Provider' award from the World Health Organization, the 2020 'Innovator of the Year' award from the International Federation of Medical Devices, and the 2021 'Best Emerging Health Technology' award from the Global Health Council.
References
